Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
16 April 2025
|
|
06:21 | Marstacimab-hncq 6 changes history +19,836 [Parth Vikram Singh (6×)] | |||
|
|
06:21 (cur | prev) +339 Parth Vikram Singh talk contribs | ||||
|
|
06:18 (cur | prev) +1,257 Parth Vikram Singh talk contribs | ||||
|
|
05:22 (cur | prev) +6,630 Parth Vikram Singh talk contribs | ||||
|
|
05:10 (cur | prev) +1,400 Parth Vikram Singh talk contribs | ||||
|
|
03:16 (cur | prev) +5,948 Parth Vikram Singh talk contribs | ||||
|
|
02:58 (cur | prev) +4,262 Parth Vikram Singh talk contribs | ||||
15 April 2025
|
|
18:26 | Marstacimab-hncq 4 changes history +2,050 [Parth Vikram Singh (4×)] | |||
|
|
18:26 (cur | prev) +540 Parth Vikram Singh talk contribs | ||||
|
|
18:21 (cur | prev) +1,017 Parth Vikram Singh talk contribs | ||||
|
|
18:15 (cur | prev) +93 Parth Vikram Singh talk contribs | ||||
|
|
18:07 (cur | prev) +400 Parth Vikram Singh talk contribs | ||||
|
|
16:37 | Zolbetuximab-clzb 7 changes history +31,130 [Parth Vikram Singh (7×)] | |||
|
|
16:37 (cur | prev) −16 Parth Vikram Singh talk contribs | ||||
|
|
16:34 (cur | prev) +7,143 Parth Vikram Singh talk contribs | ||||
|
|
16:12 (cur | prev) −1 Parth Vikram Singh talk contribs | ||||
|
|
15:56 (cur | prev) +10,908 Parth Vikram Singh talk contribs | ||||
|
|
15:35 (cur | prev) +2,198 Parth Vikram Singh talk contribs | ||||
|
|
15:30 (cur | prev) +9,551 Parth Vikram Singh talk contribs | ||||
|
|
12:43 (cur | prev) +1,347 Parth Vikram Singh talk contribs | ||||
|
|
11:28 | Mirvetuximab soravtansine-gynx 14 changes history +40,904 [Parth Vikram Singh (14×)] | |||
|
|
11:28 (cur | prev) +5,973 Parth Vikram Singh talk contribs | ||||
|
|
11:16 (cur | prev) +1,686 Parth Vikram Singh talk contribs | ||||
|
|
11:00 (cur | prev) +3 Parth Vikram Singh talk contribs | ||||
|
|
10:57 (cur | prev) +937 Parth Vikram Singh talk contribs | ||||
|
|
10:53 (cur | prev) −1 Parth Vikram Singh talk contribs | ||||
|
|
10:51 (cur | prev) −1 Parth Vikram Singh talk contribs | ||||
|
|
10:48 (cur | prev) −24 Parth Vikram Singh talk contribs | ||||
|
|
10:35 (cur | prev) +16,170 Parth Vikram Singh talk contribs | ||||
|
|
08:21 (cur | prev) +412 Parth Vikram Singh talk contribs | ||||
|
|
08:14 (cur | prev) +8,918 Parth Vikram Singh talk contribs | ||||
|
|
06:51 (cur | prev) +4,866 Parth Vikram Singh talk contribs | ||||
|
|
06:31 (cur | prev) +855 Parth Vikram Singh talk contribs | ||||
|
|
02:45 (cur | prev) +240 Parth Vikram Singh talk contribs | ||||
|
|
02:21 (cur | prev) +870 Parth Vikram Singh talk contribs | ||||
14 April 2025
13 April 2025
| N 16:35 | Mirvetuximab soravtansine-gynx diffhist +1,044 Parth Vikram Singh talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{PVS}} |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Mirvetuximab soravtansine-gynx in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Gu...") | ||||
| N 16:24 | Marstacimab-hncq diffhist +974 Parth Vikram Singh talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{PVS}} |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Marstacimab-hncq in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Guideline-Suppor...") | ||||
| N 16:23 | Zolbetuximab-clzb diffhist +979 Parth Vikram Singh talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{PVS}} |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Zolbetuximab-clzb in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Guideline-Suppo...") | ||||
10 April 2025
|
|
06:38 | Lazertinib 9 changes history +6,476 [Parth Vikram Singh (9×)] | |||
|
|
06:38 (cur | prev) +2 Parth Vikram Singh talk contribs | ||||
|
|
06:37 (cur | prev) +2,735 Parth Vikram Singh talk contribs | ||||
|
|
06:30 (cur | prev) +628 Parth Vikram Singh talk contribs | ||||
|
|
05:57 (cur | prev) +2,858 Parth Vikram Singh talk contribs | ||||
|
|
05:48 (cur | prev) −121 Parth Vikram Singh talk contribs | ||||
|
|
05:44 (cur | prev) −1 Parth Vikram Singh talk contribs | ||||
|
|
05:43 (cur | prev) −24 Parth Vikram Singh talk contribs | ||||
|
|
05:39 (cur | prev) −1 Parth Vikram Singh talk contribs | ||||
|
|
05:38 (cur | prev) +400 Parth Vikram Singh talk contribs | ||||